New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 25, 2017 – The FDA approved an AP-rated generic version of Astellas’ Prograf (tacrolimus) 5 mg/mL injection.
Download PDF
Return to publications
